XML 58 R44.htm IDEA: XBRL DOCUMENT v3.20.2
Derivative Instruments (Summary Of The Effect Of Derivative Instruments On The Consolidated Statements Of Changes In Equity And Income) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Amount of Gain (Loss) Recognized in AOCI on Derivative (Effective Portion) $ (7,691) $ (6,635) $ (4,019) $ (13,224)
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 172 146 334 284
Amount of Income (Expense) Reclassified from AOCI into Earnings (Effective Portion) (1,365) 560 (1,624) 1,469
Interest Expense 38,340 36,458 73,093 70,421
Other Income 416 5,726 7,989 6,070
Interest Rate Swap [Member]        
Amount of Income (Expense) Reclassified from AOCI into Earnings (Effective Portion) [1] (1,601) 403 (2,066) 1,178
Cross Currency Swaps [Member]        
Amount of Gain (Loss) Recognized in AOCI on Derivative (Effective Portion) (472) (165) 667 (476)
Amount of Income (Expense) Reclassified from AOCI into Earnings (Effective Portion) [2] 236 157 442 291
Cross Currency Swap 2023 [Member]        
Amount of Gain (Loss) Recognized in AOCI on Derivative (Effective Portion) (6,188) (1,057) 6,987 (4,896)
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net [2] 172 [3] 146 [3] 334 284
Interest Expense [Member] | Interest Rate Swap [Member]        
Amount of Gain (Loss) Recognized in AOCI on Derivative (Effective Portion) $ (1,031) $ (5,413) $ (11,673) $ (7,852)
[1]
(1) Included in "Interest expense, net" in the accompanying consolidated statements of (loss) income and comprehensive (loss) income for the three and six months ended June 30, 2020 and 2019.
[2]
(2) Included in "Other income" in the accompanying consolidated statements of (loss) income and comprehensive (loss) income for the three and six months ended June 30, 2020 and 2019.
[3]
(3) Amounts represent derivative gains excluded from the effectiveness testing.